10-Q Filing

ENZON PHARMACEUTICALS, INC. CIK: 727510 Q1 2023

Filing Information

Form Type	10-Q
Accession Number	`0001410578-23-000888`
Period End Date	20230331
Filing Date	20230505
Fiscal Year	2023
Fiscal Period	Q1
XBRL Instance	enzn-20230331x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 51 Income Statement 30 Cash Flow Statement 21 Stockholders Equity 12

Balance Sheet 51 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`TemporaryEquityParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$46.98M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$45.88M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$380.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$405.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$46.26M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$47.39M	USD	Point-in-time
Deferred tax asset	`DeferredIncomeTaxAssetsNet`	$202.00K	USD	Point-in-time
Deferred tax asset	`DeferredIncomeTaxAssetsNet`	$238.00K	USD	Point-in-time
Total assets	`Assets`	$47.59M	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total assets	`Assets`	$46.49M	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	2.96M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	2.96M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$331.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$331.00K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$93.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$79.00K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$77.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Dividends payable on Series C preferred stock	`DividendsPayableCurrent`	$1.27M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.70M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	74.21M	shares	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$408.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	74.21M	shares	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	74.21M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	74.21M	shares	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 2,960,000 shares; no shares issued and outstanding at March 31, 2023 and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 2,960,000 shares; no shares issued and outstanding at March 31, 2023 and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 74,214,603 shares at March 31, 2023 and December 31, 2022	`CommonStockValue`	$742.00K	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 74,214,603 shares at March 31, 2023 and December 31, 2022	`CommonStockValue`	$742.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$74.71M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$74.18M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-72.04M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-71.85M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$3.07M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$4.05M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$3.41M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$4.87M	USD	Point-in-time
Total liabilities, mezzanine equity and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$46.49M	USD	Point-in-time
Total liabilities, mezzanine equity and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$47.59M	USD	Point-in-time

Income Statement 30 line items

Line Item	Tag	Value	Unit	Period
Royalties and milestones, net	`RoyaltyRevenueAndMilestones`	-	USD	1 Quarter
Royalties and milestones, net	`RoyaltyRevenueAndMilestones`	-	USD	1 Quarter
Total revenues	`Revenues`	-	USD	1 Quarter
Total revenues	`Revenues`	-	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$285.00K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$297.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$285.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$297.00K	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-285.00K	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-297.00K	USD	1 Quarter
Interest and dividend income	`OtherInterestAndDividendIncome`	$447.00K	USD	1 Quarter
Interest and dividend income	`OtherInterestAndDividendIncome`	$2.00K	USD	1 Quarter
Income (loss) before income tax benefit (expense)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$162.00K	USD	1 Quarter
Income (loss) before income tax benefit (expense)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-295.00K	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	$-35.00K	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	$-4.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-291.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$197.00K	USD	1 Quarter
Dividends on Series C preferred stock	`PreferredStockDividendsIncomeStatementImpact`	$531.00K	USD	1 Quarter
Dividends on Series C preferred stock	`PreferredStockDividendsIncomeStatementImpact`	$531.00K	USD	1 Quarter
Net loss available to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-822.00K	USD	1 Quarter
Net loss available to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-334.00K	USD	1 Quarter
Loss per common share - Basic	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Loss per common share - Basic	`EarningsPerShareBasic`	-	USD	1 Quarter
Loss per common share - Diluted	`EarningsPerShareDiluted`	-	USD	1 Quarter
Loss per common share - Diluted	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Weighted average number of common shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	74,215.00	shares	1 Quarter
Weighted average number of common shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	74,215.00	shares	1 Quarter
Weighted average number of common shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	74,215.00	shares	1 Quarter
Weighted average number of common shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	74,215.00	shares	1 Quarter

Cash Flow Statement 21 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$197.00K	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-291.00K	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-36.00K	USD	1 Quarter
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-79.00K	USD	1 Quarter
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-9.00K	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-212.00K	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$170.00K	USD	1 Quarter
Preferred stock dividend payments	`PaymentsOfDividendsCommonStock`	$1.27M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.27M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.10M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-212.00K	USD	1 Quarter
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$47.64M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$45.88M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.98M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$47.43M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$47.64M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$45.88M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.98M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$47.43M	USD	Point-in-time
Accretion of dividend for Series C Preferred Stock	`AccretionOfDividendForSeriesCPreferredStock`	$531.00K	USD	1 Quarter
Accretion of dividend for Series C Preferred Stock	`AccretionOfDividendForSeriesCPreferredStock`	$531.00K	USD	1 Quarter

Stockholders Equity 12 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$3.07M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.05M	USD	Point-in-time
Balance	`StockholdersEquity`	$3.41M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.87M	USD	Point-in-time
Net income (loss)	`NetIncomeLoss`	$-291.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$197.00K	USD	1 Quarter
Preferred stock dividend accumulation	`DividendsPreferredStockStock`	$531.00K	USD	1 Quarter
Preferred stock dividend accumulation	`DividendsPreferredStockStock`	$531.00K	USD	1 Quarter
Balance	`StockholdersEquity`	$3.07M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.05M	USD	Point-in-time
Balance	`StockholdersEquity`	$3.41M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.87M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.